30 Years of Evidence
Join the experts’ corner
Featured Content
SBRT Focal Boost for Localised Prostate Cancer: Primary Outcomes of the SPARC Prospective Trial
Efficacy and Toxicity of Moderately Hypofractionated Radiotherapy via Helical TomoTherapy versus Conventional Radiotherapy Combined with Concurrent Chemotherapy for Patients with Unresectable
Stage III NSCLC
Feasibility of SBRT with CyberKnife in the Scenario of Lung Metastases Re-RT: Monoinstitutional Experience
PO-1365: SBRT for locally recurrent prostate cancer after prostatectomy and post-operative radiotherapy
Wojciech Majewski, Bartlomiej Goc, Donata Graupner, Marcin Miszczyk | ESTRO | 2022
PO-1315: CT radiomic predictors of local relapse after SBRT for lung oligometastases from colorectal cancer
Martina Mori, Roberta Tummineri, Simone Baroni, Michela Olivieri, Sara Broggi, Chiara Lucrezia Deantoni, Paola Mangili, Andrei Fodor, Antonella Del Vecchio, Claudio Antonio Fiorino, Nadia Gisella Di Muzio | ESTRO | 2022
PO-1261: Is SBRT an effective treatment in metastatic lung cancer with oligoprogressive disease?
Michele Aquilano, Mauro Loi, Lorenzo Livi, Joost Nuyttens | ESTRO | 2022
PD-0411: Predictive factors of late GU toxicity after Cyberknife re-irradiation for locally recurrent PCa
Giulio Francolini, Cecilia Cerbai, Mauro Loi, Vanessa Di Cataldo, Beatrice Detti, Gabriele Simontacchi, Lucia Pia Ciccone, Laura Masi, Raffaella Doro, Andrea Allegra, Viola Salvestrini, Chiara Mattioli, Giulio Frosini, Luca Burchini, Michele Aquilano, Giulia Stocchi, Isacco Desideri, Lorenzo Livi | ESTRO | 2022
PO-1228: Radiosurgery in her2-breast cancer brain metastasis:local control and overall survival in 32 women
Samantha Dicuonzo, Francesca Colombo, Luca Bergamaschi, Gaia Piperno, Annamaria Ferrari, Maria Cristina Leonardi, Mattia Zaffaroni, Maria Alessia Zerella, Damaris Patricia Rojas, Marianna Alessandra Gerardi, Anna Morra, Elena Rondi, Sabrina Vigorito, Federica Cattani, Roberto Orecchia, Barbara Alicja Jereczek-Fossa, Samuele Frassoni, Vincenzo Bagnardi | ESTRO | 2022
PO-1392: SBRT monotherapy for low and intermediate risk Prostate Cancer. First Chilean experience
María Fernanda Sánchez, Felipe Maza, Federico Bakal, Piero Bettoli | ESTRO | 2022
PO-1372: Robotic stereotactic body radiotherapy for prostate cancer : an initial monoistitutional experience
Ariadna Sanchez Galvan, Andrei Fodor, Claudio Fiorino, Paola Mangilli, Chiara Lucrezia Deantoni, Cesare Cozzarini, Roberta Tummineri, Simone Baroni, Stefano Lorenzo Villa, Giuseppina Mandurino, Pietro Pacifico, Stefano Arcangeli, Nadia Gisella Di Muzio | ESTRO | 2022
PO-1370: Metastasis-Directed Therapy with Cyberknife for Oligometastatic Prostate Cancer
Sebastian Exner, Fabian Fehlauer, Saul Esteve Grau | ESTRO | 2022